National prime vendor
Ended Awarded Last action
- Contract number
- SPE2DU26F0Q23
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,499
Award facts
- Contract value 100% obligated
- $3,498.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,498.82 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on January 12, 2026, with a completion date of January 13, 2026, represents one of numerous firm fixed-price orders placed under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the agency. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to Department of Defense healthcare facilities, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and over-the-counter drugs.
This delivery order operates under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy through which the Defense Logistics Agency establishes regional prime vendor contractors to support recurring medical supply needs for military healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under this program designated SPE2DR, which was awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. The underlying IDC includes a 30-month base period with three 30-month option periods, positioning the contractor as a critical pharmaceutical supplier for Department of Defense global healthcare operations.
Quick answers
Who was awarded contract SPE2DU26F0Q23?
SPE2DU26F0Q23 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DU26F0Q23 worth?
The government has obligated $3,499 on SPE2DU26F0Q23.
Is contract SPE2DU26F0Q23 an order under another contract?
Yes. SPE2DU26F0Q23 is a delivery order under SPE2DU25D9818, an indefinite delivery contract.
Was contract SPE2DU26F0Q23 competed?
The extent of competition for SPE2DU26F0Q23 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award